Navigation Links
£6.5M in funding to help manufacture the drugs of the future
Date:2/5/2013

e potential of stem cell therapies can be realised.

  • Linking recombinant gene sequence to protein product manufacturability using CHO cell genomic resources. University of Sheffield.
    • Bioinformatics and mathematics will be used to assess how efficiently mammalian cells can be used to harvest proteins manufacture specific proteins. This information will be used to create "design rules" that genetic engineers and cell factory developers can employ to design the most effective genetic code for a given protein product, and predict how much the mammalian cell factory can make.

  • Development of an integrated continuous process for recombinant protein production using Pichia pastoris. University of Cambridge.
    • Building on previous BRIC funding, the research will investigate an efficient way to ensure continuous target protein production in the yeast Pichia pastoris.

  • Development of new-generation bacterial secretion process platforms. University of Warwick.
    • Research will investigate a pathway to export target proteins manufactured in bacteria such as E. coli which offers potential for exporting proteins that the other pathways cannot support, and enable refinement of products of particularly high quality.

  • Commercial scale manufacture of adult allogeneic cell therapy University College London.
    • Universal cell lines of olfactory ensheathing cells will be cultured and assessed for regeneration potential.

  • Improving biopharmaceutical production in microbial systems: engineering GlycoPEGylation in E. coli. University of Sheffield.
    • Researchers will aim to produce an example therapeutic protein in the bacterium E. coli that can be purified and efficiently modified to improve its biological and physical characteristics and thus overall effectiveness.

  • Bioprocessing of high concentration protein solutions: quality by digital design
    '/>"/>

  • Contact: Chris Melvin
    press.office@bbsrc.ac.uk
    44-179-341-4694
    Biotechnology and Biological Sciences Research Council
    Source:Eurekalert

    Page: 1 2 3 4 5

    Related biology news :

    1. Chronic disease research awarded funding
    2. Lake Erie wind farm proposal wins $4 million in federal funding
    3. 23andMe scientists receive more than $500,000 in National Institutes of Health funding
    4. Clinician-scientists at The Neuro receive funding for Parkinsons and HIV research
    5. £12 million funding to tackle devastating livestock and poultry viruses
    6. University spin-out company shares in £7.9 million marine energy funding boost
    7. State stem cell research funding agency awards $37.3 million to aid UC Irvine efforts
    8. 2 pioneering plant genomics efforts given a funding boost by National Science Foundation
    9. University of Minnesota receives $13.1 million in DOE funding for 2 new nationwide centers
    10. Space research institute awards funding to promising medical products
    11. House funding bill will delay research progress and place new burdens on NIH
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/16/2014)... severe respiratory tract infections and worldwide claims the ... VIB and Ghent University have succeeded in developing ... virus infection. , Xavier Saelens (VIB/UGent): "We ... way for the development of a novel approach ... suffering in numerous small children and elderly people." ...
    (Date:10/15/2014)... N.Y. , Oct. 15, 2014 ... solutions for home and community-based care, today announced ... of implementing Sandata,s Santrax® Electronic Visit Verification™ Solution ... Services is a home health company founded in ... Texas . The study ...
    (Date:10/15/2014)... Johannes Gutenberg University Mainz (JGU) as a full ... to maintain a significant nationwide standing in the ... of Johannes Gutenberg University Mainz as a full ... the national and international competition for the best ... can be proud that Mainz University has been ...
    Breaking Biology News(10 mins):New perspectives for development of an RSV vaccine 2Sandata Announces Case Study with Quality Care Services, Inc. 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3
    ... stiff after middle age, a new study has revealed., In ... for the effects of obesity. But after middle age, this ... fat rises potentially increasing the risk of dying from ... body fat may be related to the total number of ...
    ... 14, 2013 /PRNewswire-iReach/ -- With specialized home health care, ... dementia -- can remain in their homes instead of ... is often preferable for the patients themselves and their ... visiting caregivers, is now providing specialized dementia and Alzheimer,s ...
    ... -- Recent studies that examine links between sodium consumption and ... very high levels some Americans consume now, but evidence from ... below 2,300 mg per day, says a new report from ... past several decades to reduce dietary intake of sodium, a ...
    Cached Biology News:Body fat hardens arteries after middle age 2AegisCare Offers Specialized Home Health Care for Dementia and Alzheimer's Patients 2Studies support population-based efforts to lower excessive dietary sodium intakes 2Studies support population-based efforts to lower excessive dietary sodium intakes 3
    (Date:10/25/2014)... (PRWEB) October 24, 2014 This ... PHA, PBS, Starch Based Plastics, Regenerated Cellulose, PCL), ... Global Trends and Forecasts to 2019”, defines and ... analysis and forecast of its global volume and ... 54 Figures spread through 178 Slides and in-depth ...
    (Date:10/25/2014)... SonaCare Medical, LLC, leader in minimally ... that its Board of Directors has appointed Dr. ... and member of the Board effective immediately. In ... responsibilities within the company, including further developing the ... manufacturing and finance. , Dr. Carol joined ...
    (Date:10/25/2014)... 25, 2014 Berkshire Corporation, the ... to announce the release of the ValuSeal® IonX™ ... of contamination containment in critical processing applications. , ... higher cleanroom environments, ValuSeal® IonX™ is a laser ... wiper that continues Berkshire’s innovative focus on meeting ...
    (Date:10/25/2014)... and NEW YORK ... Inc. (OTCQB: ACCPD), formerly Access Pharmaceuticals, Inc. (ACCP), ... areas, announced it has implemented a 1-for-50 reverse ... opening of trading on Friday, October 24, 2014. ... basis under new CUSIP number 72754H109 and temporary ...
    Breaking Biology Technology:Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 2Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 3Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 4SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 2SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 3Ions Are Bygones, Berkshire Announces the Release of New Innovative Cleanroom Wipers 2PlasmaTech Biopharmaceuticals, Inc. Announces Reverse Stock Split, Ticker Change and Launches New Corporate Website 2
    ... Shareholders Re-elect Directors and Ratify Auditor at Annual Meeting, ... Directors,of Baxter International Inc. (NYSE: BAX ) today ... Annual Meeting of Shareholders,held earlier today., Baxter,s Board ... of Baxter common stock. This payment represents a continuation ...
    ... 6 There are a lot of steps,between a ... force must be involved with many of those steps ... re-launch effort,according to a study by benchmarking leader Best ... force? Half of the companies that,participated in the research ...
    ... - Dalton Pharma Services, a privately ... Fisher Scientific,have entered into an agreement ... proprietary,Thermo Fisher manufacturing process to produce ... enzyme-based technology developed at Thermo Fisher,Scientific,s ...
    Cached Biology Technology:Invigorated Sales Force Key to a Successful Re-Launch 2Dalton Pharma Services Licenses Thermo Fisher Scientific Technology to Produce Polynucleotides for Drug Development 2Dalton Pharma Services Licenses Thermo Fisher Scientific Technology to Produce Polynucleotides for Drug Development 3
    ... The Jouan MSC series of Class ... working conditions and certification to the ... regulation ensures that the cabinets cannot ... conditions. Natural lighting, low noise and ...
    ... HM-4000 Multidizer is designed with a variety ... rotating - all in one unit. Shake, ... independently operating compartments allow for hybridization and ... motion , The upper chamber uses ...
    ... MSC series of Class II Biological ... and certification to the world's highest ... that the cabinets cannot be adjusted ... lighting, low noise and arm rest ...
    ... Sensitive Bio (for heat-labile and very volatile ... to specific applications of molecular biology and ... heat-labile samples. The RC systems can be ... and a wide selection of rotors (eliminating ...
    Biology Products: